December 13, 2016 / 7:21 AM / 8 months ago

BRIEF-Shilpa Medicare gets USFDA approval for capecitabine tablets USP

Dec 13 (Reuters) - Shilpa Medicare Ltd

* Shilpa Medicare -got approval from USFDA for capecitabine tablets USP, 150 mg and 500 mg to be bioequivalent and therapeutically equivalent to reference listed drug product Source text - (bit.ly/2hhc5Bl) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below